Cell therapy for ischaemic stroke

David C Hess, William D Hill

Research output: Contribution to journalArticle

10 Citations (Scopus)

Abstract

While acute neuroprotection in acute stroke has proven difficult and ended in many failures, there is increasing interest in restorative therapies that target brain remodelling. Cell therapy (transplantation of cells) shows promise, with a growing body of pre-clinical evidence demonstrating improved functional outcomes in animal models; however, questions still remain concerning mechanisms of action. Clinical trials are already underway and will increase in the next few years; their appropriate design and execution along with continued pre-clinical work are necessary for the field to advance and satisfy a large unmet clinical need.

Original languageEnglish (US)
Pages (from-to)1-8
Number of pages8
JournalCell Proliferation
Volume44
Issue numberSUPPL. 1
DOIs
StatePublished - Apr 1 2011

Fingerprint

Cell Transplantation
Cell- and Tissue-Based Therapy
Animal Models
Stroke
Clinical Trials
Brain
Therapeutics
Neuroprotection

ASJC Scopus subject areas

  • Cell Biology

Cite this

Cell therapy for ischaemic stroke. / Hess, David C; Hill, William D.

In: Cell Proliferation, Vol. 44, No. SUPPL. 1, 01.04.2011, p. 1-8.

Research output: Contribution to journalArticle

Hess, David C ; Hill, William D. / Cell therapy for ischaemic stroke. In: Cell Proliferation. 2011 ; Vol. 44, No. SUPPL. 1. pp. 1-8.
@article{58622b4129ce426e9b251b6b4ae406bd,
title = "Cell therapy for ischaemic stroke",
abstract = "While acute neuroprotection in acute stroke has proven difficult and ended in many failures, there is increasing interest in restorative therapies that target brain remodelling. Cell therapy (transplantation of cells) shows promise, with a growing body of pre-clinical evidence demonstrating improved functional outcomes in animal models; however, questions still remain concerning mechanisms of action. Clinical trials are already underway and will increase in the next few years; their appropriate design and execution along with continued pre-clinical work are necessary for the field to advance and satisfy a large unmet clinical need.",
author = "Hess, {David C} and Hill, {William D}",
year = "2011",
month = "4",
day = "1",
doi = "10.1111/j.1365-2184.2010.00718.x",
language = "English (US)",
volume = "44",
pages = "1--8",
journal = "Cell Proliferation",
issn = "0960-7722",
publisher = "Wiley-Blackwell",
number = "SUPPL. 1",

}

TY - JOUR

T1 - Cell therapy for ischaemic stroke

AU - Hess, David C

AU - Hill, William D

PY - 2011/4/1

Y1 - 2011/4/1

N2 - While acute neuroprotection in acute stroke has proven difficult and ended in many failures, there is increasing interest in restorative therapies that target brain remodelling. Cell therapy (transplantation of cells) shows promise, with a growing body of pre-clinical evidence demonstrating improved functional outcomes in animal models; however, questions still remain concerning mechanisms of action. Clinical trials are already underway and will increase in the next few years; their appropriate design and execution along with continued pre-clinical work are necessary for the field to advance and satisfy a large unmet clinical need.

AB - While acute neuroprotection in acute stroke has proven difficult and ended in many failures, there is increasing interest in restorative therapies that target brain remodelling. Cell therapy (transplantation of cells) shows promise, with a growing body of pre-clinical evidence demonstrating improved functional outcomes in animal models; however, questions still remain concerning mechanisms of action. Clinical trials are already underway and will increase in the next few years; their appropriate design and execution along with continued pre-clinical work are necessary for the field to advance and satisfy a large unmet clinical need.

UR - http://www.scopus.com/inward/record.url?scp=79953838912&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79953838912&partnerID=8YFLogxK

U2 - 10.1111/j.1365-2184.2010.00718.x

DO - 10.1111/j.1365-2184.2010.00718.x

M3 - Article

C2 - 21481036

AN - SCOPUS:79953838912

VL - 44

SP - 1

EP - 8

JO - Cell Proliferation

JF - Cell Proliferation

SN - 0960-7722

IS - SUPPL. 1

ER -